All you need to know about Tramadol

Tramadol 

Tramadol is an opioid analgesic.  It was first manufactured in Germany with the generic name “Ultram”. It is prescribed to treat moderate to moderately sever pain and is considered a safer alternative to other narcotic analgesics like hydrocodone, and methadone.
It is delivered in two forms.
For medical purposes, such as surgeries or for severe pain, it is given intravenously as an injection or passed as drips.
It is sold in Nigeria in tablet form and green capsules of between 50mg to 400mg. When taken in pill form at high doses, some of its less desirous side-effects include nausea, diarrhea, loss of appetite and dry mouth.
In the inverse, tramadol, can produce a euphoric similar to another commonly abused opiate medication, oxycodone (OxyContin).
Although Tramadol is not the strongest of analgesics, it is a darling on prescription lists. That’s because unlike other opioids such as methadone and fentany1, Tramadol is not internationally regulated, hence it is cheap and readily available for patients. Doctors prescribe tramadol in case of post-surgical pains, bone deficiencies and cancer.
However, in the last decade, Nigeria has been a significant rise in the non-medical use of Tramadol, which produces similar effects to the “high” caused by heroin.


Reasons why Tramadol is been  abused in Nigeria 


  1. In addition to its  highness, it is also abused for the feeling of numbness from pain, lucidity and extreme alertness that it gives by heightening the senses.
  2. The numbness that Tramadol brings is one of the main reasons why it has become a drug of choice. Users describe the feeling high on tramadol as “forgetting everything that does not matter”, especially when combined with alcohol.
  3. The popularity of tramadol brings is not only for its pain relief. Abusers believe it enhances sexual performance in men, Researchers believe Tramadol’s aphrodisiac properties could stem from its anatagonism of serotonin receptors hence delaying ejaculation.





THERE IS LOVE IN SHARING! :

No comments:

Post a comment